ACTUALIZACIÓN COVID EN G&O

ACTUALIZACIÓN COVID EN G&O

Safety, tolerability, and immunogenicity of a recombinant adenovirus TYPE-5 vectored COVID-19 vaccine:  a dose-escalation, open-label, non-randomised, first-in-human trial

Safety, tolerability, and immunogenicity of a recombinant adenovirus TYPE-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial